Abstract
Enteropathogenic Escherichia coli are bacterial pathogens that colonize the gut and cause severe diarrhea in humans. Upon intimate attachment to the intestinal epithelium, these pathogens translocate via a type III secretion system virulent proteins, termed effectors, into the host cells. These effectors manipulate diverse host cell organelles and functions for the pathogen’s benefit. However, the precise mechanisms underlying their activities are not fully understood despite intensive research. EspH, a critical effector protein, has been previously reported to disrupt the host cell actin cytoskeleton by suppressing RhoGTPase guanine exchange factors. However, native host proteins targeted by EspH to mediate these activities remained unknown. Here, we identified the active Bcr related (ABR), a protein previously characterized to possess dual Rho guanine nucleotide exchange factor and GTPase activating protein (GAP) domains, as a native EspH interacting partner. These interactions are mediated by the effector protein’s C-terminal 38 amino acid segment. The effector primarily targets the GAP domain of ABR to suppress Rac1 and Cdc42, host cell cytotoxicity, bacterial invasion, and filopodium formation at infection sites. Knockdown of ABR expression abolished the ability of EspH to suppress Rac1, Cdc42. Our studies unravel a novel mechanism by which host RhoGTPases are hijacked by bacterial effectors.
Original language | American English |
---|---|
Article number | 2130657 |
Journal | Gut Microbes |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - 2022 |
Bibliographical note
Funding Information:This work was supported by the Israel Science Foundation [1671/19]. This research was supported by a grant from the Israel Science Foundation (1671/19). Rachana Ramachandran and Ipsita Nandi are recipients of the Dr. Willem Been Legacy Fellowship. We thank Prof. Ilan Rosenshine’s Lab (Hadassah Medical School; The Hebrew University of Jerusalem) for providing reagents, bacterial strains, and insightful discussions.
Funding Information:
This research was supported by a grant from the Israel Science Foundation (1671/19). Rachana Ramachandran and Ipsita Nandi are recipients of the Dr. Willem Been Legacy Fellowship. We thank Prof. Ilan Rosenshine’s Lab (Hadassah Medical School; The Hebrew University of Jerusalem) for providing reagents, bacterial strains, and insightful discussions.
Publisher Copyright:
© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.
Keywords
- Enteropathogenic E. coli
- EspH
- Rho GTPases
- Type III secreted effectors
- active Bcr related (ABR)
- host-pathogen interactions